T-Heart Overview
- Year Founded
-
2018
- Status
-
Private
- Employees
-
8
- Latest Deal Type
-
Series A1
- Latest Deal Amount
-
$2.92M
- Investors
-
1
T-Heart General Information
Description
Developer of a transcatheter tricuspid valve replacement system designed to eliminate tricuspid regurgitation in diseased and enlarged tricuspid valves. The company offers a proprietary anchoring structure, a biomimetic valve design, and a one-step implantation procedure, enabling patients with tricuspid valve disease to improve cardiac function and quality of life.
Contact Information
Website
theartvalve.comCorporate Office
- 74 Rue du Faubourg, Saint Antoine
- 75012 Paris
- France
Corporate Office
- 74 Rue du Faubourg, Saint Antoine
- 75012 Paris
- France
T-Heart Timeline
T-Heart Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Later Stage VC (Series A1) | 05-Jun-2026 | $2.92M | Completed | Pre-Clinical Trials | ||
| 5. Later Stage VC | 01-Jun-2025 | Completed | Startup | |||
| 4. Later Stage VC | 03-Apr-2023 | Completed | Generating Revenue | |||
| 3. Early Stage VC | 16-Jul-2021 | Completed | Product Development | |||
| 2. Early Stage VC | 29-May-2020 | $3.28M | $6.68M | Completed | Product Development | |
| 1. Early Stage VC | 19-Jul-2019 | $3.4M | $3.4M | Completed | Startup |
T-Heart Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Shares A | ||||||||
| Shares A |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
T-Heart Comparisons
Industry
Financing
Details
T-Heart Competitors (2)
One of T-Heart’s 2 competitors is TRiCares, a Venture Capital-Backed company based in Aschheim, Germany.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| TRiCares | Venture Capital-Backed | Aschheim, Germany | ||||
| Cardiovalve | Formerly VC-backed | Or Yehuda, Israel |
T-Heart Patents
T-Heart Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2023412838-A1 | Loading system for a stent device | Pending | 20-Dec-2022 | ||
| EP-4637633-A1 | Loading system for a stent device | Pending | 20-Dec-2022 | ||
| US-20260207361-A1 | Loading system for a stent device | Pending | 20-Dec-2022 | ||
| WO-2024132115-A1 | Loading system for a stent device | Inactive | 20-Dec-2022 | ||
| WO-2024132887-A1 | Loading system for a stent device | Inactive | 20-Dec-2022 | A61F2/9525 |
T-Heart Signals
T-Heart Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| iBionext | Accelerator/Incubator | Minority |
T-Heart FAQs
-
When was T-Heart founded?
T-Heart was founded in 2018.
-
Where is T-Heart headquartered?
T-Heart is headquartered in Paris, France.
-
What is the size of T-Heart?
T-Heart has 8 total employees.
-
What industry is T-Heart in?
T-Heart’s primary industry is Surgical Devices.
-
Is T-Heart a private or public company?
T-Heart is a Private company.
-
What is the current valuation of T-Heart?
The current valuation of T-Heart is .
-
What is T-Heart’s current revenue?
The current revenue for T-Heart is .
-
How much funding has T-Heart raised over time?
T-Heart has raised $19.7M.
-
Who are T-Heart’s investors?
iBionext has invested in T-Heart.
-
Who are T-Heart’s competitors?
TRiCares and Cardiovalve are competitors of T-Heart.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process